Final steps of natural killer cell maturation: a model for type 1 type 2 differentiation?

被引:144
作者
Loza, MJ [1 ]
Perussia, B [1 ]
机构
[1] Thomas Jefferson Univ, Jefferson Med Coll, Kimmel Canc Ctr, Dept Microbiol & Immunol, Philadelphia, PA 19107 USA
关键词
D O I
10.1038/ni1001-917
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Analysis of cytokine and differentiation antigen expression in human natural killer (NK) cells revealed that interleukin 13 (IL-13) and interferon gamma (IFN-gamma) are produced at sequential stages during irreversible IL-12-induced differentiation. In human NK cell clones, polyclonal CD3(-)CD161(+)CD56(-) cells and peripheral lymphocytes, IL-4 induced the proliferation of both IL-13. NK and T cells, whereas IL-12 allowed a proliferation-independent accumulation of IFN-gamma (+) cells. These data disproved the NK1-NK2 hypothesis and challenge the current T helper 1 (THI)-T(H)2 paradigm. We propose that the cytokine environment regulates a type 2 -->0 -->1 developmental progression, with IL-12 needed for terminal differentiation and IL-4 delaying this process, rather than a type 1 versus type 2 decision of a type 0 cell.
引用
收藏
页码:917 / 924
页数:8
相关论文
共 32 条
[1]   COOPERATION OF NATURAL-KILLER-CELL STIMULATORY FACTOR INTERLEUKIN-12 WITH OTHER STIMULI IN THE INDUCTION OF CYTOKINES AND CYTOTOXIC CELL-ASSOCIATED MOLECULES IN HUMAN T-CELLS AND NK-CELLS [J].
ASTEAMEZAGA, M ;
DANDREA, A ;
KUBIN, M ;
TRINCHIERI, G .
CELLULAR IMMUNOLOGY, 1994, 156 (02) :480-492
[2]   Definition of a natural killer NKR-P1A(+)/CD56(-)/CD16(-) functionally immature human NK cell subset that differentiates in vitro in the presence of interleukin 12 [J].
Bennett, IM ;
Zatsepina, O ;
Zamai, L ;
Azzoni, L ;
Mikheeva, T ;
Perussia, B .
JOURNAL OF EXPERIMENTAL MEDICINE, 1996, 184 (05) :1845-1856
[3]  
Cella M, 2000, METH MOL B, V121, P1
[4]   PRODUCTION OF HEMATOPOIETIC COLONY-STIMULATING FACTORS BY HUMAN NATURAL-KILLER CELLS [J].
CUTURI, MC ;
ANEGON, I ;
SHERMAN, F ;
LOUDON, R ;
CLARK, SC ;
PERUSSIA, B ;
TRINCHIERI, G .
JOURNAL OF EXPERIMENTAL MEDICINE, 1989, 169 (02) :569-583
[5]   PRODUCTION OF NATURAL-KILLER-CELL STIMULATORY FACTOR (INTERLEUKIN-12) BY PERIPHERAL-BLOOD MONONUCLEAR-CELLS [J].
DANDREA, A ;
RENGARAJU, M ;
VALIANTE, NM ;
CHEHIMI, J ;
KUBIN, M ;
ASTE, M ;
CHAN, SH ;
KOBAYASHI, M ;
YOUNG, D ;
NICKBARG, E ;
CHIZZONITE, R ;
WOLF, SF ;
TRINCHIERI, G .
JOURNAL OF EXPERIMENTAL MEDICINE, 1992, 176 (05) :1387-1398
[6]   Cloning and characterization of TRAIL-R3, a novel member of the emerging TRAIL receptor family [J].
DegliEsposti, MA ;
Smolak, PJ ;
Walczak, H ;
Waugh, J ;
Huang, CP ;
DuBose, RF ;
Goodwin, RG ;
Smith, CA .
JOURNAL OF EXPERIMENTAL MEDICINE, 1997, 186 (07) :1165-1170
[7]   EFFECTS OF INTERFERON-GAMMA ON CELL-DIFFERENTIATION AND CYTOKINE PRODUCTION OF A HUMAN MONOBLAST CELL-LINE, U937 [J].
ISHIZUKA, T ;
HIRATA, I ;
ADACHI, M ;
KURIMOTO, F ;
HISADA, T ;
DOBASHI, K ;
MORI, M .
INFLAMMATION, 1995, 19 (06) :627-636
[8]   IDENTIFICATION AND PURIFICATION OF NATURAL-KILLER CELL STIMULATORY FACTOR (NKSF), A CYTOKINE WITH MULTIPLE BIOLOGIC EFFECTS ON HUMAN-LYMPHOCYTES [J].
KOBAYASHI, M ;
FITZ, L ;
RYAN, M ;
HEWICK, RM ;
CLARK, SC ;
CHAN, S ;
LOUDON, R ;
SHERMAN, F ;
PERUSSIA, B ;
TRINCHIERI, G .
JOURNAL OF EXPERIMENTAL MEDICINE, 1989, 170 (03) :827-845
[9]   Type 1 and type 2 cytokine dysregulation in human infectious, neoplastic, and inflammatory diseases [J].
Lucey, DR ;
Clerici, M ;
Shearer, GM .
CLINICAL MICROBIOLOGY REVIEWS, 1996, 9 (04) :532-+
[10]   DETERMINATION OF LYMPHOCYTE DIVISION BY FLOW-CYTOMETRY [J].
LYONS, AB ;
PARISH, CR .
JOURNAL OF IMMUNOLOGICAL METHODS, 1994, 171 (01) :131-137